TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
drugdeliverybusiness12d
Dexcom CGM worn in outer space on Polaris Dawn mission
Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...
drugdeliverybusiness3h
Ypsomed reports positive outcomes with automated insulin delivery for maternal health
Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being ...
Joplin Globe13d
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts ...
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
Wells Fargo Remains a Buy on Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) on September 13 and set a price target of ...